Antagonists at Metabotropic Glutamate Receptor Subtype 5
- 23 October 2008
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1141 (1) , 221-232
Abstract
As a result of intensive investigation, particularly in the pharmaceutical industry, a number of potent and selective metabotropic glutamate receptor subtype 5 (mGluR5) antagonists have been discovered. The structure activity relationship studies that led to the discovery of these mGluR5 antagonists are presented in this review. Results from studies on selected mGluR5 antagonists in animal models that simulate drug reward, reinforcement, and relapse appear promising. The comorbidity between drug abuse and anxiety and depression make drugs active in these disorders of great interest. Clinical studies showed that the mGluR5 antagonist fenobam was an active anxiolytic drug. Several new mGluR5 antagonists produced anxiolytic and antidepressant‐like effects in animal models of these disorders. The results from the clinical and animal studies provide information for new approaches to finding mechanistically distinct pharmacotherapies to help patients achieve and maintain abstinence from cocaine, methamphetamine, opiates, ethanol, and nicotine (smoking).Keywords
This publication has 73 references indexed in Scilit:
- Rational design of 7-arylquinolines as non-competitive metabotropic glutamate receptor subtype 5 antagonistsBioorganic & Medicinal Chemistry Letters, 2007
- Stress, Dysregulation of Drug Reward Pathways, and the Transition to Drug DependenceAmerican Journal of Psychiatry, 2007
- Discovery of heterobicyclic templates for novel metabotropic glutamate receptor subtype 5 antagonistsBioorganic & Medicinal Chemistry Letters, 2007
- Design and synthesis of novel heterobiaryl amides as metabotropic glutamate receptor subtype 5 antagonistsBioorganic & Medicinal Chemistry Letters, 2007
- Metabotropic Glutamate Receptor Subtype 5 Antagonists MPEP and MTEPCNS Drug Reviews, 2006
- Dipyridyl amines: Potent metabotropic glutamate subtype 5 receptor antagonistsBioorganic & Medicinal Chemistry Letters, 2005
- Discovery of highly potent, selective, orally bioavailable, metabotropic glutamate subtype 5 (mGlu5) receptor antagonists devoid of cytochrome P450 1A2 inhibitory activityBioorganic & Medicinal Chemistry Letters, 2004
- Discovery of Novel Heteroarylazoles That Are Metabotropic Glutamate Subtype 5 Receptor Antagonists with Anxiolytic ActivityJournal of Medicinal Chemistry, 2004
- Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant miceNature Neuroscience, 2001
- Molecular Cloning and the Functional Expression of Two Isoforms of Human Metabotropic Glutamate Receptor Subtype 5Biochemical and Biophysical Research Communications, 1994